The European Rare Diseases Research Alliance (ERDERA) is excited to announce the upcoming launch of its Joint Transnational Call (JTC) for Proposals 2025. Set to officially open on December 10, 2024, this call will invite research teams from across Europe and beyond to submit collaborative projects focused on “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.”
The primary objective of the call is to support interdisciplinary, transnational collaborations that leverage complementary expertise to develop new therapies for rare diseases. Research projects should focus on pre-clinical studies involving small molecules or biologicals. This could include the development of novel therapies, biomarkers for therapy efficiency, or replication of pre-clinical studies to validate findings.
The JTC 2025 will follow a two-stage submission process:
December 10, 2024: Call opens.
February 13, 2025: Pre-proposal submission deadline.
July 9, 2025: Full proposal submission deadline.
Funding decisions are expected by December 2025.
You may find the pre-announcement document here. Please note that this is a draft announcement and the list of funders is not final.
Interested applicants can join an informational webinar on December 17, 2024, for guidance on preparing submissions.
For further details, please click here.